Andres Gonzalez-Jimenez
Biography
|
Andres Gonzalez-Jimenez currently works at the Department of Pharmacology and Pediatrics, University of Malaga. Andres does research in Clinical Pharmacology, Epidemiology and Bioinformatics. Their current project is 'Host factors, Drug properties and their interaction in the development of Drug-induced liver injury'. |
Profile
| Institution | IBIMA Plataforma BIONAND |
| Position | Coordinador Tecnico Bioinformatico de apoyo a la investigacion |
| Home page | https://www.linkedin.com/in/andres-gonzalez-jimenez-2b4a9661 |
| Contact email | bioinformatica@ibima.eu |
| ORCID | 0000-0002-7059-1577 |
BCB Hub
| BCB Committee | Not a member |
| BCB Tools | |
| BCB Services | Bioinformatics Core at IBIMA Plataforma BIONAND |
Publications 57 entries
- Comparative effectiveness of two alternative dosing strategies of pembrolizumab in metastatic non-small-cell lung cancer in a real-world setting Article · 1 Jul 2026
- Neutrophils blend innate and adaptive immunity in early breast milk Article · 22 May 2026
- Rurality, risk factors, and stage at diagnosis in head and neck cancer: insights from a Spanish hospital Article · 10 Feb 2026
- New insights into the molecular biology of Alzheimer’s-like cerebral amyloidosis achieved through multi‐omics approaches Article · 3 Sep 2025
- Targeting Lymphedema in Overweight Breast Cancer Survivors: A Pilot Randomized Controlled Trial of Diet and Exercise Intervention Article · 27 Aug 2025
View all (52 more)
- Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study Article · 8 Aug 2025
- Evaluation of the role of comedication properties in the severity of drug-induced liver injury using machine learning techniques Article · 6 Jul 2025
- Pathogenicity assessment of genetic variants identified in patients with severe hypertriglyceridemia: novel cases of Familial Chylomicronemia Syndrome from the Dyslipidemia Registry of the Spanish Atherosclerosis Society. Article · May 2025
- Serum miR-365b-5p/miR-222-5p as a potential diagnostic biomarker for long-term weight loss in patients with morbid obesity after bariatric surgery Article · Apr 2025
- Epigenetic modifications in drug‐induced liver injury: A systematic review Article · 25 Mar 2025
- Pre-operative DNA methylation marks as predictors of weight loss outcomes after sleeve gastrectomy Article · Feb 2025
- Interactions between the gut microbiome and DNA methylation patterns in blood and visceral adipose tissue in subjects with different metabolic characteristics Article · 1 Dec 2024
- Neutrophils as indicators of obesity‐associated inflammation: A systematic review and meta‐analysis Article · 29 Nov 2024
- Epigenetic profiles in blood and adipose tissue: identifying strong correlations in morbidly obese and non-obese patients Article · 3 Sep 2024
- Effects of the Ketogenic Diet on Strength Performance in Trained Men and Women: A Systematic Review and Meta-Analysis Article · 10 Jul 2024
- Correction: A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle Article · 24 May 2024
- A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle Article · 4 May 2024
- Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation Article · 15 Feb 2024
- Epigenetic Marks as Predictors of Metabolic Response to Bariatric Surgery: Validation from an Epigenome Wide Association Study Article · 30 Sep 2023
- Multi-Omics Approach Reveals Prebiotic and Potential Antioxidant Effects of Essential Oils from the Mediterranean Diet on Cardiometabolic Disorder Using Humanized Gnotobiotic Mice Article · 20 Aug 2023
- Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial Article · 3 Mar 2023
- Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology Article · 21 Jul 2022
- Evaluation of Adipose Tissue Zinc-Alpha 2-Glycoprotein Gene Expression and Its Relationship with Metabolic Status and Bariatric Surgery Outcomes in Patients with Class III Obesity Article · 25 Jun 2022
- Mitochondrial Homeostasis in Obesity-related Hypertriglyceridemia Article · 24 May 2022
- A revised electronic version of RUCAM for the diagnosis of DILI Article · 22 Mar 2022
- Epigenetic Biomarkers of Transition from Metabolically Healthy Obesity to Metabolically Unhealthy Obesity Phenotype: A Prospective Study Article · 27 Sep 2021
- Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI Article · Aug 2021
- Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry Article · Jul 2021
- Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach Article · 5 Mar 2021
- Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI Registry Article · 16 Nov 2020
- Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review Article · Jul 2019
- FRI-077-Influence of drug categorization according to labelling information in the phenotypic presentation of drug-induced liver injury (DILI): An analysis in the Spanish DILI registry Article · Apr 2019
- The influence of drug properties and host factors on delayed onset of symptoms in drug‐induced liver injury Article · 29 Sep 2018
- Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry Article · Sep 2018
- Independent cohort validation of hepatic metabolism, daily dose and comorbidities as features associated with delayed symptom onset in drug-induced liver injury Article · Apr 2018
- DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome Article · Apr 2018
- High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries Article · Feb 2018
- Hepatic Damage by Natural Remedies Article · Feb 2018
- Data Mining for Possible Drug-Host Interplay in Clinical Phenotypes of Drug-Induced Liver Injury Article · Apr 2017
- Influence of host characteristics and pharmacological properties on type of liver injury in hepatotoxicity Article · 2017
- Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry Article · 2017
- Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions Article · Oct 2016
- Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury Article · Sep 2016
- The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative Article · 29 Feb 2016
- Hepatotoxicity Associated with Non-Steroidal Anti-Inflammatory Drugs. A Comparative Analysis among Ibuprofen, Diclofenac and Nimesulide fromthe Spanish and Latin-American Dili Registries Article · 2016
- Metabolic risk factors affect clinical Phenotype and outcome of Hepatotoxicity (DILI) Article · Aug 2015
- Hepatotoxicity related to Herbals and Dietary Supplements (HDS): a cause for concern Article · Aug 2015
- The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity Article · 8 Apr 2015
- P1098 : Influence of metabolic risk factors in hepatotoxicity (DILI) phenotype and outcome Article · Apr 2015
- P1097 : Distinguishing drug induced autoimmune hepatitis from idiopatic autoimmune hepatitis Article · Apr 2015
- Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids Article · 13 Nov 2014
- Use of hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury Article · Jul 2014
- P310 ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH–LATIN-AMERICAN DILI REGISTRY Article · Apr 2014
- P309 PROGNOSTIC MODEL FOR PREDICTING DRUG-INDUCED ACUTE LIVER FAILURE Article · Apr 2014
- PP025—Improving hy’s law definition to better predict the risk of developing acute liver failure in drug-induced liver injury (DILI) Article · Aug 2013
- PP022—Variations in drug-induced liver injury (DILI) between different prospective dili registries Article · Aug 2013
- 518 THE SPANISH–LATIN AMERICAN DILI NETWORK: PRELIMINARY RESULTS FROM A COLLABORATIVE STRATEGIC INITIATIVE Article · Apr 2013